60 results
424B3
SYRE
Spyre Therapeutics Inc.
15 May 24
Prospectus supplement
4:06pm
for substantially the full term of the liability. The Parapyre Option Obligation is measured each period using a Black-Scholes model to estimate the fair … the weighted-average Black-Scholes option pricing model assumptions used to estimate the fair value of stock options granted under the Company’s equity incentive
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
in the valuation of the CVR liability; inputs used in the Black-Scholes model for stock-based compensation expense; estimated future cash flows used in calculating … in the Black-Scholes model for stock-based compensation expense; estimated future cash flows used in calculating the impairment ofright-of-use
lease assets
POS AM
oiqduiupbr98x5it
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
5fg dsab4dd
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
8-K
EX-99.2
a89xj njd
15 Nov 23
Other Events
5:14pm
8-K
EX-99.1
7ftvmvzhs63
24 Oct 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
kzey1p0
10 Oct 23
Report of Independent Registered Public Accounting Firm
12:00am